Assure (IOM) Shares Down 27.7%

Share on StockTwits

Assure Holdings Corp (CVE:IOM) shares were down 27.7% during trading on Friday . The company traded as low as C$1.70 and last traded at C$1.70. Approximately 127,300 shares traded hands during trading, an increase of 742% from the average daily volume of 15,119 shares. The stock had previously closed at C$2.35.

The company has a current ratio of 4.58, a quick ratio of 4.56 and a debt-to-equity ratio of 4.82. The company has a market cap of $80.14 million and a P/E ratio of -56.67.

TRADEMARK VIOLATION WARNING: This piece was published by Zolmax and is the property of of Zolmax. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this piece can be viewed at https://zolmax.com/investing/assure-iom-shares-down-27-7/2983525.html.

About Assure (CVE:IOM)

Assure Holdings Corp., together with its subsidiaries, delivers technical and professional surgical support services in connection with inter operative neuro-monitoring procedures. It provides risk mitigation services to make underlying surgeries safer. The company is based in Denver, Colorado.

See Also: What does EPS mean?

Receive News & Ratings for Assure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assure and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Analysts Expect Bank of Hawaii Co.  to Announce $1.38 Earnings Per Share
Analysts Expect Bank of Hawaii Co. to Announce $1.38 Earnings Per Share
Soarcoin 1-Day Trading Volume Tops $220.00
Soarcoin 1-Day Trading Volume Tops $220.00
Mason Graphite  Shares Up 5.6%
Mason Graphite Shares Up 5.6%
Continental Gold  Shares Up 0.7%
Continental Gold Shares Up 0.7%
Arcus Biosciences Inc  Short Interest Update
Arcus Biosciences Inc Short Interest Update
Hancock Whitney Corp  Given Average Rating of “Buy” by Analysts
Hancock Whitney Corp Given Average Rating of “Buy” by Analysts


 
© 2006-2019 Zolmax.